TD Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61.6M | Sell |
680,527
-62,285
| -8% | -$5.22M | 0.05% | 263 |
|
|
2026
Q1 | $59.5M | Sell |
742,812
-35,317
| -5% | -$2.91M | 0.05% | 278 |
|
|
2025
Q4 | $66.3M | Buy |
778,129
+47,051
| +6% | +$3.86M | 0.05% | 259 |
|
|
2025
Q3 | $56.9M | Sell |
731,078
-12,562
| -2% | -$982K | 0.05% | 294 |
|
|
2025
Q2 | $58.2M | Sell |
743,640
-167,546
| -18% | -$12.5M | 0.05% | 282 |
|
|
2025
Q1 | $66M | Sell |
911,186
-93,165
| -9% | -$6.67M | 0.06% | 264 |
|
|
2024
Q4 | $74.4M | Sell |
1,004,351
-80,362
| -7% | -$5.62M | 0.07% | 244 |
|
|
2024
Q3 | $72.2M | Sell |
1,084,713
-330,152
| -23% | -$24M | 0.06% | 259 |
|
|
2024
Q2 | $131M | Sell |
1,414,865
-48,443
| -3% | -$4.29M | 0.12% | 158 |
|
|
2024
Q1 | $140M | Buy |
1,463,308
+139,697
| +11% | +$11.7M | 0.13% | 159 |
|
|
2023
Q4 | $101M | Buy |
1,323,611
+645,204
| +95% | +$44.9M | 0.1% | 179 |
|
|
2023
Q3 | $47M | Buy |
678,407
+108,904
| +19% | +$8.75M | 0.06% | 261 |
|
|
2023
Q2 | $53.7M | Sell |
569,503
-27,020
| -5% | -$2.35M | 0.06% | 245 |
|
|
2023
Q1 | $49.4M | Sell |
596,523
-3,570
| -0.6% | -$281K | 0.06% | 254 |
|
|
2022
Q4 | $44.8M | Buy |
600,093
+223,128
| +59% | +$17.2M | 0.06% | 275 |
|
|
2022
Q3 | $31.6M | Buy |
376,965
+5,473
| +1% | +$527K | 0.04% | 324 |
|
|
2022
Q2 | $35.3M | Sell |
371,492
-7,833
| -2% | -$811K | 0.04% | 321 |
|
|
2022
Q1 | $44.7M | Buy |
379,325
+1,064
| +0.3% | +$119K | 0.04% | 310 |
|
|
2021
Q4 | $49M | Sell |
378,261
-18,390
| -5% | -$2.15M | 0.04% | 332 |
|
|
2021
Q3 | $44.9M | Sell |
396,651
-2,057
| -0.5% | -$235K | 0.05% | 303 |
|
|
2021
Q2 | $44.8M | Sell |
398,708
-13,029
| -3% | -$1.23M | 0.05% | 313 |
|
|
2021
Q1 | $34.4M | Buy |
411,737
+32,459
| +9% | +$2.74M | 0.04% | 352 |
|
|
2020
Q4 | $34.6M | Buy |
379,278
+2,449
| +0.6% | +$203K | 0.04% | 323 |
|
|
2020
Q3 | $30.1M | Buy |
376,829
+144,979
| +63% | +$11.3M | 0.04% | 308 |
|
|
2020
Q2 | $16M | Sell |
231,850
-3,386
| -1% | -$241K | 0.02% | 404 |
|
|
2020
Q1 | $14.8M | Buy |
235,236
+13,383
| +6% | +$965K | 0.03% | 386 |
|
|
2019
Q4 | $17.3M | Sell |
221,853
-19,764
| -8% | -$1.54M | 0.03% | 415 |
|
|
2019
Q3 | $17.7M | Sell |
241,617
-9,081
| -4% | -$638K | 0.03% | 387 |
|
|
2019
Q2 | $15.4M | Sell |
250,698
-6,165
| -2% | -$373K | 0.02% | 416 |
|
|
2019
Q1 | $16.4M | Sell |
256,863
-5,145
| -2% | -$294K | 0.03% | 400 |
|
|
2018
Q4 | $13.4M | Buy |
262,008
+8,685
| +3% | +$439K | 0.02% | 422 |
|
|
2018
Q3 | $14.7M | Buy |
253,323
+6,438
| +3% | +$315K | 0.02% | 452 |
|
|
2018
Q2 | $12M | Buy |
246,885
+6,984
| +3% | +$326K | 0.02% | 486 |
|
|
2018
Q1 | $11.2M | Sell |
239,901
-2,934
| -1% | -$127K | 0.02% | 495 |
|
|
2017
Q4 | $9.12M | Buy |
242,835
+3,606
| +2% | +$132K | 0.01% | 543 |
|
|
2017
Q3 | $8.72M | Sell |
239,229
-11,532
| -5% | -$440K | 0.01% | 541 |
|
|
2017
Q2 | $9.88M | Sell |
250,761
-4,893
| -2% | -$179K | 0.02% | 526 |
|
|
2017
Q1 | $8.02M | Sell |
255,654
-4,263
| -2% | -$133K | 0.01% | 585 |
|
|
2016
Q4 | $8.12M | Sell |
259,917
-45,861
| -15% | -$1.49M | 0.01% | 564 |
|
|
2016
Q3 | $12.3M | Sell |
305,778
-13,398
| -4% | -$505K | 0.02% | 472 |
|
|
2016
Q2 | $10.6M | Buy |
319,176
+9,534
| +3% | +$326K | 0.02% | 498 |
|
|
2016
Q1 | $9.1M | Sell |
309,642
-10,362
| -3% | -$286K | 0.02% | 520 |
|
|
2015
Q4 | $8.43M | Buy |
320,004
+4,200
| +1% | +$109K | 0.02% | 522 |
|
|
2015
Q3 | $7.48M | Sell |
315,804
-87,000
| -22% | -$2.1M | 0.01% | 528 |
|
|
2015
Q2 | $9.56M | Sell |
402,804
-88,398
| -18% | -$1.99M | 0.02% | 520 |
|
|
2015
Q1 | $11.7M | Buy |
491,202
+160,542
| +49% | +$3.6M | 0.02% | 459 |
|
|
2014
Q4 | $7.02M | Sell |
330,660
-28,128
| -8% | -$565K | 0.01% | 586 |
|
|
2014
Q3 | $6.11M | Buy |
358,788
+28,956
| +9% | +$457K | 0.01% | 589 |
|
|
2014
Q2 | $4.72M | Sell |
329,832
-24,000
| -7% | -$325K | 0.01% | 665 |
|
|
2014
Q1 | $4.37M | Sell |
353,832
-21,000
| -6% | -$242K | 0.01% | 677 |
|
|
2013
Q4 | $4.11M | Sell |
374,832
-35,400
| -9% | -$399K | 0.01% | 685 |
|
|
2013
Q3 | $4.76M | Sell |
410,232
-334,200
| -45% | -$3.91M | 0.01% | 616 |
|
|
2013
Q2 | $8.34M | Buy |
+744,432
| New | +$8.81M | 0.02% | 450 |
|
Other funds holding EW
VCM
VPM
TD Asset Management's EW Position: Q2 2026 in Review
TD Asset Management reduced its Edwards Lifesciences (EW) stake by 8.4% in Q2 2026, selling an estimated $5.22M and leaving 680,527 shares worth $61.6M. The position accounts for 0.05% of the portfolio, ranked #263.
TD Asset Management first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $140M in Q1 2024. 1,086 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- TD Asset Management held 680,527 shares of Edwards Lifesciences worth $61.6M as of Q2 2026.
- TD Asset Management sold 62,285 Edwards Lifesciences shares in Q2 2026, an estimated $5.22M.
- Edwards Lifesciences made up 0.05% of TD Asset Management's portfolio in Q2 2026, its #263 holding.
- TD Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- TD Asset Management's Edwards Lifesciences position peaked at $140M in Q1 2024.
- 1,086 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.